APO Research
Talk to an analyst

APO RESEARCH · REPORT

Orthopedic Hyaluronic Acid Viscosupplementation

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Orthopedic Hyaluronic Acid Viscosupplementation Market Outlook and Growth Opportunities 2026

22 December 2025192 pages

Choose your research edition.

Industry ResearchOrthopedic Hyaluronic Acid Viscosupplementation Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Orthopedic Hyaluronic Acid Viscosupplementation Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Orthopedic Hyaluronic Acid Viscosupplementation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Orthopedic Hyaluronic Acid Viscosupplementation Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Orthopedic Hyaluronic Acid Viscosupplementation Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Orthopedic Hyaluronic Acid Viscosupplementation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Orthopedic Hyaluronic Acid Viscosupplementation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Orthopedic Hyaluronic Acid Viscosupplementation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Orthopedic Hyaluronic Acid Viscosupplementation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Orthopedic Hyaluronic Acid Viscosupplementation market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Orthopedic Hyaluronic Acid Viscosupplementation market include Haohai Biological, Sanofi, Shanghai Jingfeng, Ferring, Zimmer Biomet, Seikagaku, LG Chem, Freda and Bioventus, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Orthopedic Hyaluronic Acid Viscosupplementation market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Orthopedic Hyaluronic Acid Viscosupplementation and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Orthopedic Hyaluronic Acid Viscosupplementation sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Orthopedic Hyaluronic Acid Viscosupplementation market size, projected growth trends, production technologies, key applications, and end-use industries.

Orthopedic Hyaluronic Acid Viscosupplementation Segment by Company

Haohai Biological

Sanofi

Shanghai Jingfeng

Ferring

Zimmer Biomet

Seikagaku

LG Chem

Freda

Bioventus

Anika Therapeutics

Orthopedic Hyaluronic Acid Viscosupplementation Segment by Type

Five Injection

Three Injection

Single Injection

Orthopedic Hyaluronic Acid Viscosupplementation Segment by Application

Hospitals

Clinics

Others

Orthopedic Hyaluronic Acid Viscosupplementation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Orthopedic Hyaluronic Acid Viscosupplementation status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Orthopedic Hyaluronic Acid Viscosupplementation market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Orthopedic Hyaluronic Acid Viscosupplementation significant trends, drivers, influence factors in global and regions.

6. To analyze Orthopedic Hyaluronic Acid Viscosupplementation competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Orthopedic Hyaluronic Acid Viscosupplementation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Orthopedic Hyaluronic Acid Viscosupplementation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Orthopedic Hyaluronic Acid Viscosupplementation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Orthopedic Hyaluronic Acid Viscosupplementation market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Orthopedic Hyaluronic Acid Viscosupplementation industry.

Chapter 3: Detailed analysis of Orthopedic Hyaluronic Acid Viscosupplementation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Orthopedic Hyaluronic Acid Viscosupplementation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Orthopedic Hyaluronic Acid Viscosupplementation in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Orthopedic Hyaluronic Acid Viscosupplementation Industry Trends Table 2. Orthopedic Hyaluronic Acid Viscosupplementation Industry Drivers Table 3. Orthopedic Hyaluronic Acid Viscosupplementation Industry Opportunities and Challenges Table 4. Orthopedic Hyaluronic Acid Viscosupplementation Industry Restraints Table 5. Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue Share by Company (2021-2026) Table 7. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Volume by Company (k units) & (2021-2026) Table 8. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Volume Share by Company (2021-2026) Table 9. Global Orthopedic Hyaluronic Acid Viscosupplementation Average Price (US$/unit) of Company (2021-2026) Table 10. Global Orthopedic Hyaluronic Acid Viscosupplementation Company Ranking, (2024-2026) & (USD Million) Table 11. Global Orthopedic Hyaluronic Acid Viscosupplementation Key Company Manufacturing Base & Headquarters Table 12. Global Orthopedic Hyaluronic Acid Viscosupplementation Company, Product Type & Application Table 13. Global Orthopedic Hyaluronic Acid Viscosupplementation Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Orthopedic Hyaluronic Acid Viscosupplementation by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Five Injection Table 18. Significant Companies of Three Injection Table 19. Significant Companies of Single Injection Table 20. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Volume by Type (2021-2026) & (k units) Table 22. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Volume by Type (2027-2032) & (k units) Table 23. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Volume Share by Type (2021-2026) Table 24. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Volume Share by Type (2027-2032) Table 25. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type (2021-2026) Table 29. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospitals Table 31. Significant Companies of Clinics Table 32. Significant Companies of Others Table 33. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Volume by Application (2021-2026) & (k units) Table 35. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Volume by Application (2027-2032) & (k units) Table 36. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Volume Share by Application (2021-2026) Table 37. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Volume Share by Application (2027-2032) Table 38. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application (2021-2026) Table 42. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application (2027-2032) Table 43. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Region (2021-2026) & (k units) Table 45. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Market Share by Region (2021-2026) Table 46. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Region (2027-2032) & (k units) Table 47. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Market Share by Region (2027-2032) Table 48. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Region (2021-2026) Table 51. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Region (2027-2032) Table 53. Global Orthopedic Hyaluronic Acid Viscosupplementation Market Average Price (US$/unit) by Region (2021-2026) Table 54. Global Orthopedic Hyaluronic Acid Viscosupplementation Market Average Price (US$/unit) by Region (2027-2032) Table 55. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Country (2021-2026) & (k units) Table 58. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Market Share by Country (2021-2026) Table 59. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Country (2027-2032) & (k units) Table 60. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Market Share by Country (2027-2032) Table 61. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Market Share by Country (2021-2026) Table 63. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Market Share by Country (2027-2032) Table 65. Haohai Biological Company Information Table 66. Haohai Biological Business Overview Table 67. Haohai Biological Orthopedic Hyaluronic Acid Viscosupplementation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. Haohai Biological Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio Table 69. Haohai Biological Recent Development Table 70. Sanofi Company Information Table 71. Sanofi Business Overview Table 72. Sanofi Orthopedic Hyaluronic Acid Viscosupplementation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. Sanofi Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio Table 74. Sanofi Recent Development Table 75. Shanghai Jingfeng Company Information Table 76. Shanghai Jingfeng Business Overview Table 77. Shanghai Jingfeng Orthopedic Hyaluronic Acid Viscosupplementation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Shanghai Jingfeng Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio Table 79. Shanghai Jingfeng Recent Development Table 80. Ferring Company Information Table 81. Ferring Business Overview Table 82. Ferring Orthopedic Hyaluronic Acid Viscosupplementation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Ferring Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio Table 84. Ferring Recent Development Table 85. Zimmer Biomet Company Information Table 86. Zimmer Biomet Business Overview Table 87. Zimmer Biomet Orthopedic Hyaluronic Acid Viscosupplementation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Zimmer Biomet Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio Table 89. Zimmer Biomet Recent Development Table 90. Seikagaku Company Information Table 91. Seikagaku Business Overview Table 92. Seikagaku Orthopedic Hyaluronic Acid Viscosupplementation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Seikagaku Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio Table 94. Seikagaku Recent Development Table 95. LG Chem Company Information Table 96. LG Chem Business Overview Table 97. LG Chem Orthopedic Hyaluronic Acid Viscosupplementation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. LG Chem Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio Table 99. LG Chem Recent Development Table 100. Freda Company Information Table 101. Freda Business Overview Table 102. Freda Orthopedic Hyaluronic Acid Viscosupplementation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Freda Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio Table 104. Freda Recent Development Table 105. Bioventus Company Information Table 106. Bioventus Business Overview Table 107. Bioventus Orthopedic Hyaluronic Acid Viscosupplementation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. Bioventus Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio Table 109. Bioventus Recent Development Table 110. Anika Therapeutics Company Information Table 111. Anika Therapeutics Business Overview Table 112. Anika Therapeutics Orthopedic Hyaluronic Acid Viscosupplementation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. Anika Therapeutics Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio Table 114. Anika Therapeutics Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Orthopedic Hyaluronic Acid Viscosupplementation Distributors List Table 118. Orthopedic Hyaluronic Acid Viscosupplementation Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Orthopedic Hyaluronic Acid Viscosupplementation Product Image Figure 2. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value (2021-2032) & (US$ Million) Figure 4. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales (2021-2032) & (k units) Figure 5. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Orthopedic Hyaluronic Acid Viscosupplementation Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Five Injection Image Figure 10. Three Injection Image Figure 11. Single Injection Image Figure 12. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Volume Share by Type (2021-2032) Figure 15. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type (2021-2032) Figure 18. Hospitals Image Figure 19. Clinics Image Figure 20. Others Image Figure 21. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Volume Share by Application (2021-2032) Figure 24. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application (2021-2032) Figure 27. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Orthopedic Hyaluronic Acid Viscosupplementation Sales Value (2021-2032) & (US$ Million) Figure 32. North America Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Orthopedic Hyaluronic Acid Viscosupplementation Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Orthopedic Hyaluronic Acid Viscosupplementation Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Orthopedic Hyaluronic Acid Viscosupplementation Sales Value (2021-2032) & (US$ Million) Figure 38. South America Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Orthopedic Hyaluronic Acid Viscosupplementation Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Orthopedic Hyaluronic Acid Viscosupplementation Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Orthopedic Hyaluronic Acid Viscosupplementation Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Five Injection
  • Three Injection
  • Single Injection
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Haohai Biological
  • Sanofi
  • Shanghai Jingfeng
  • Ferring
  • Zimmer Biomet
  • Seikagaku
  • LG Chem
  • Freda
  • Bioventus
  • Anika Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value (2021-2032)
  4. 1.2.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Volume (2021-2032)
  5. 1.2.3 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Orthopedic Hyaluronic Acid Viscosupplementation Market Dynamics
  1. 2.1 Orthopedic Hyaluronic Acid Viscosupplementation Industry Trends
  2. 2.2 Orthopedic Hyaluronic Acid Viscosupplementation Industry Drivers
  3. 2.3 Orthopedic Hyaluronic Acid Viscosupplementation Industry Opportunities and Challenges
  4. 2.4 Orthopedic Hyaluronic Acid Viscosupplementation Industry Restraints
3 Orthopedic Hyaluronic Acid Viscosupplementation Market by Company
  1. 3.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Company Revenue Ranking in 2025
  2. 3.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Company (2021-2026)
  3. 3.3 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Volume by Company (2021-2026)
  4. 3.4 Global Orthopedic Hyaluronic Acid Viscosupplementation Average Price by Company (2021-2026)
  5. 3.5 Global Orthopedic Hyaluronic Acid Viscosupplementation Company Ranking (2024-2026)
  6. 3.6 Global Orthopedic Hyaluronic Acid Viscosupplementation Company Manufacturing Base and Headquarters
  7. 3.7 Global Orthopedic Hyaluronic Acid Viscosupplementation Company Product Type and Application
  8. 3.8 Global Orthopedic Hyaluronic Acid Viscosupplementation Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Orthopedic Hyaluronic Acid Viscosupplementation Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Orthopedic Hyaluronic Acid Viscosupplementation Market by Type
  1. 4.1 Orthopedic Hyaluronic Acid Viscosupplementation Type Introduction
  2. 4.1.1 Five Injection
  3. 4.1.2 Three Injection
  4. 4.1.3 Single Injection
  5. 4.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Volume by Type
  6. 4.2.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value by Type
  10. 4.3.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value by Type (2021-2032)
  12. 4.3.3 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type (2021-2032)
5 Orthopedic Hyaluronic Acid Viscosupplementation Market by Application
  1. 5.1 Orthopedic Hyaluronic Acid Viscosupplementation Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Volume by Application
  6. 5.2.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value by Application
  10. 5.3.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value by Application (2021-2032)
  12. 5.3.3 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application (2021-2032)
6 Orthopedic Hyaluronic Acid Viscosupplementation Regional Sales and Value Analysis
  1. 6.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Region (2021-2032)
  3. 6.2.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Region: 2021-2026
  4. 6.2.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Region (2027-2032)
  5. 6.3 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value by Region (2021-2032)
  7. 6.4.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value by Region: 2021-2026
  8. 6.4.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value by Region (2027-2032)
  9. 6.5 Global Orthopedic Hyaluronic Acid Viscosupplementation Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Orthopedic Hyaluronic Acid Viscosupplementation Sales Value (2021-2032)
  12. 6.6.2 North America Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Orthopedic Hyaluronic Acid Viscosupplementation Sales Value (2021-2032)
  15. 6.7.2 Europe Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Orthopedic Hyaluronic Acid Viscosupplementation Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Orthopedic Hyaluronic Acid Viscosupplementation Sales Value (2021-2032)
  21. 6.9.2 South America Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Orthopedic Hyaluronic Acid Viscosupplementation Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Country, 2025 VS 2032
7 Orthopedic Hyaluronic Acid Viscosupplementation Country-level Sales and Value Analysis
  1. 7.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Country (2021-2032)
  4. 7.3.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Country (2021-2026)
  5. 7.3.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Country (2027-2032)
  6. 7.4 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value by Country (2021-2032)
  7. 7.4.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value by Country (2021-2026)
  8. 7.4.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Orthopedic Hyaluronic Acid Viscosupplementation Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Haohai Biological
  2. 8.1.1 Haohai Biological Company Information
  3. 8.1.2 Haohai Biological Business Overview
  4. 8.1.3 Haohai Biological Orthopedic Hyaluronic Acid Viscosupplementation Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Haohai Biological Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
  6. 8.1.5 Haohai Biological Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Orthopedic Hyaluronic Acid Viscosupplementation Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Shanghai Jingfeng
  14. 8.3.1 Shanghai Jingfeng Company Information
  15. 8.3.2 Shanghai Jingfeng Business Overview
  16. 8.3.3 Shanghai Jingfeng Orthopedic Hyaluronic Acid Viscosupplementation Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shanghai Jingfeng Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
  18. 8.3.5 Shanghai Jingfeng Recent Developments
  19. 8.4 Ferring
  20. 8.4.1 Ferring Company Information
  21. 8.4.2 Ferring Business Overview
  22. 8.4.3 Ferring Orthopedic Hyaluronic Acid Viscosupplementation Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Ferring Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
  24. 8.4.5 Ferring Recent Developments
  25. 8.5 Zimmer Biomet
  26. 8.5.1 Zimmer Biomet Company Information
  27. 8.5.2 Zimmer Biomet Business Overview
  28. 8.5.3 Zimmer Biomet Orthopedic Hyaluronic Acid Viscosupplementation Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Zimmer Biomet Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
  30. 8.5.5 Zimmer Biomet Recent Developments
  31. 8.6 Seikagaku
  32. 8.6.1 Seikagaku Company Information
  33. 8.6.2 Seikagaku Business Overview
  34. 8.6.3 Seikagaku Orthopedic Hyaluronic Acid Viscosupplementation Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Seikagaku Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
  36. 8.6.5 Seikagaku Recent Developments
  37. 8.7 LG Chem
  38. 8.7.1 LG Chem Company Information
  39. 8.7.2 LG Chem Business Overview
  40. 8.7.3 LG Chem Orthopedic Hyaluronic Acid Viscosupplementation Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 LG Chem Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
  42. 8.7.5 LG Chem Recent Developments
  43. 8.8 Freda
  44. 8.8.1 Freda Company Information
  45. 8.8.2 Freda Business Overview
  46. 8.8.3 Freda Orthopedic Hyaluronic Acid Viscosupplementation Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Freda Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
  48. 8.8.5 Freda Recent Developments
  49. 8.9 Bioventus
  50. 8.9.1 Bioventus Company Information
  51. 8.9.2 Bioventus Business Overview
  52. 8.9.3 Bioventus Orthopedic Hyaluronic Acid Viscosupplementation Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Bioventus Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
  54. 8.9.5 Bioventus Recent Developments
  55. 8.10 Anika Therapeutics
  56. 8.10.1 Anika Therapeutics Company Information
  57. 8.10.2 Anika Therapeutics Business Overview
  58. 8.10.3 Anika Therapeutics Orthopedic Hyaluronic Acid Viscosupplementation Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Anika Therapeutics Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
  60. 8.10.5 Anika Therapeutics Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Orthopedic Hyaluronic Acid Viscosupplementation Value Chain Analysis
  2. 9.1.1 Orthopedic Hyaluronic Acid Viscosupplementation Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Orthopedic Hyaluronic Acid Viscosupplementation Sales Mode & Process
  6. 9.2 Orthopedic Hyaluronic Acid Viscosupplementation Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Orthopedic Hyaluronic Acid Viscosupplementation Distributors
  9. 9.2.3 Orthopedic Hyaluronic Acid Viscosupplementation Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst